Cyclophosphamide (NSC-26271) , vincristine (NSC-67574) , cytosine arabinoside (NSC-63878) , and prednisone (NSC-10023) (COAP) combination chemotherapy for acute leukemia in adults
Whitecar, J.P.; Bodey, G.P.; Freireich, E.J.; McCredie, K.B.; Hart, J.S.
Cancer ChemoTherapy Reports 56(4): 543-550
1972
ISSN/ISBN: 0069-0112 PMID: 5081596 Document Number: 53281
Document emailed within 1 workday
Related Documents
Burns, C.P. 1975: Daunorubicin (NSC-82151), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) combination therapy for advanced adult acute leukemia Cancer ChemoTherapy Reports 59(4): 757-760Gingrich, R.D.; Armitage, J.O.; Burns, C.P. 1978: Treatment of adult acute lymphoblastic leukemia with cytosine arabinoside, vincristine, and prednisone Cancer Treatment Reports 62(9): 1389-1391
Bodey, G.P.; Rodriguez, V.; Hart, J.; Freireich, E.J. 1970: Therapy of acute leukemia with the combination of cytosine arabinoside (NSC-63878) and cyclophosphamide (NSC-26271) Cancer ChemoTherapy Reports 54(4): 255-262
Avilés-Miranda, A.; Monroy-Arellano, L.M.; Conte-Lanza, G.; Morales-Polanco, M.R.; Pizzuto-Chávez, J. 1980: Combined chemotherapy: prednisone, cytosine arabinose and vincristine in the treatment of acute non-lymphoblastic leukemia in the adult Gaceta Medica de Mexico 116(8): 359-364
Tirelli, U.; Carbone, A.; Veronesi, A.; Galligioni, E.; Trovò, M.G.; Tumolo, S.; Grigoletto, E. 1982: Combination chemotherapy with cyclophosphamide, vincristine, and prednisone (CVP) in TNM-classified stage IV mycosis fungoides Cancer Treatment Reports 66(1): 167-169
Hainsworth, J.D.; Wolff, S.N.; Stein, R.S.; Greer, J.P.; Cousar, J.B.; Greco, F.A. 1986: Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis Cancer Treatment Reports 70(8): 953-958
Takemoto, Y.; Sampi, K.; Kuraishi, Y.; Okabe, K.; Tamura, K.; Mizoguchi, H.; Saito, H.; Masaoka, T.; Ogawa, M. 1999: A prospective randomized trial of KRN8602 and cytosine arabinoside vs. daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia. the KRN8602 Leukemia Study Group International Journal of Hematology 70(1): 20-25
Lin, S.F.; Liu, H.W.; Chen, T.P. 1990: Chemotherapy for acute non-lymphocytic leukemia with low-dose cytosine arabinoside (Ara-C) Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 53(1): 45-50
Baran, Y.; Gunduz, U.; Ural, A.U. 2006: Cross-resistance to cytosine arabinoside in human acute myeloid leukemia cells selected for resistance to vincristine Experimental Oncology 28(2): 163-165
Ramsay, N.K.; Coccia, P.F.; Krivit, W.; Bloomfield, C.D.; Nesbit, M.E. 1976: Vinblastine, procarbazine, and cytosine arabinoside in combination for reinduction of childhood acute myelocytic leukemia Cancer Treatment Reports 60(11): 1683-1685
Leone, G.; Pagano, L.; Marra, R.; Landolfi, R.; Cudillo, L.; Storti, S.; Mango, G.; Alfano, G.; D'Onofrio, G. 1987: Combination of 6-mercaptopurine, vincristine, methotrexate, and prednisone in resistant or relapsed acute nonlymphoid leukemia Cancer Treatment Reports 71(7-8): 751-753
Wang, Y.F.; Curtis, J.E.; Lipton, J.; Minkin, S.; McCulloch, E.A.; Lipton, M. 1991: Cytosine arabinoside (ara-C) and cis-dichlorodiammineplatinum Ii (cisplatin) alone and in combination: effects on acute myeloblastic leukemia blast cells in culture and in vivo Leukemia 5(6): 522-527
Hansen, M.M.; Bloomfield, C.D.; Jørgensen, J.; Ersbøll, J.; Pedersen-Bjergaard, J.; Blom, J.; Nissen, N.I. 1980: VP-16-213 in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone in the treatment of non-Hodgkin's lymphomas Cancer Treatment Reports 64(10-11): 1135-1137
Taguchi, H.; Kubonishi, I.; Takehara, N.; Uemura, Y.; Iwahara, Y.; Eguchi, T.; Miyagi, T.; Sugito, S.; Muneishi, H.; Tanaka, Y. 1992: Intensive induction chemotherapy of adult acute myelogenous leukemia by continuing daunorubicin, behenoyl-cytosine arabinoside, 6-mercaptopurine and prednisolone until marrow aplasia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(9): 1309-1314
Huang, H.; Lian, L.; Huang, R. 1995: Response of ovarian endodermal sinus tumor to combination chemotherapy with cis-platinum, vincristine and bleomycin or vincristine, actinomycin and cyclophosphamide Zhonghua Fu Chan Ke Za Zhi 30(5): 265-269
Anderson, J.; Krivit, W.; Chilcote, R.; Pyesmany, A.; Chard, R.; Hammond, D. 1981: Comparison of the therapeutic response of patients with childhood acute lymphoblastic leukemia in relapse to vindesine versus vincristine in combination with prednisone and L-asparaginase: a phase IIi trial Cancer Treatment Reports 65(11-12): 1015-1019
Cetkovský, P.; Koza, V.; Cepelák, V.; Vít, L. 1994: Hemostasis in patients with acute leukemia treated with high doses of cytosine-arabinoside: the effect of chemotherapy and infectious complications on hemostasis Vnitrni Lekarstvi 40(11): 730-734
Wiernik, P.H.; Schimpff, S.C.; Schiffer, C.A.; Lichtenfeld, J.L.; Aisner, J.; O'connell, M.J.; Fortner, C. 1976: Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia Cancer Treatment Reports 60(1): 41-53
Derulska, D.; Rokicka-Milewska, R. 1975: Cytosine arabinoside in the treatment of acute leukemia in children Pediatria Polska 50(6): 723-728
Hirschmann, W.D.; Kovacs, E.L.; Gerecke, D.; Kaulen, H.D.; Voigtmann, R.; Gross, R. 1975: Method of administration and inactivation of cytosine arabinoside in acute leukemia Verhandlungen der Deutschen Gesellschaft für Innere Medizin 81: 1114-1116